Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer
Mice
Administration, Intravesical
Urinary Bladder Neoplasms
Tumor Microenvironment
Animals
Humans
Dendritic Cells
Immunotherapy
CD8-Positive T-Lymphocytes
Neoplasm Recurrence, Local
3. Good health
DOI:
10.1126/scitranslmed.abd1346
Publication Date:
2021-05-19T19:11:43Z
AUTHORS (4)
ABSTRACT
Fc-optimized CD40 agonist antibodies drive local and systemic immunity against bladder cancer in mice.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (58)
CITATIONS (58)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....